N-[3-[(5-ethynyl-2-pyridinyl)oxy]-1-methylindazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;bis(N-[1-methyl-3-[(6-methyl-2-pyridinyl)oxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine);2-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]oxypyridine-3-carbonitrile;N-[1-methyl-3-(pyridin-4-ylmethoxy)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-pyridin-2-yloxyindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine

C120H95N43O6 — CID 159913345

IUPACN-[3-[(5-ethynyl-2-pyridinyl)oxy]-1-methylindazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;bis(N-[1-methyl-3-[(6-methyl-2-pyridinyl)oxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine);2-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]oxypyridine-3-carbonitrile;N-[1-methyl-3-(pyridin-4-ylmethoxy)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-pyridin-2-yloxyindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine
SMILESC#Cc1ccc(Oc2nn(C)c3cc(Nc4n[nH]c5cccnc45)ccc23)nc1.Cc1cccc(Oc2nn(C)c3cc(Nc4n[nH]c5cccnc45)ccc23)n1.Cc1cccc(Oc2nn(C)c3cc(Nc4n[nH]c5cccnc45)ccc23)n1.Cn1nc(OCc2ccncc2)c2ccc(Nc3n[nH]c4cccnc34)cc21.Cn1nc(Oc2ccccn2)c2ccc(Nc3n[nH]c4cccnc34)cc21.Cn1nc(Oc2ncccc2C#N)c2ccc(Nc3n[nH]c4cccnc34)cc21
InChIInChI=1S/C21H15N7O.C20H14N8O.3C20H17N7O.C19H15N7O/c1-3-13-6-9-18(23-12-13)29-21-15-8-7-14(11-17(15)28(2)27-21)24-20-19-16(25-26-20)5-4-10-22-19;1-28-16-10-13(24-18-17-15(25-26-18)5-3-8-22-17)6-7-14(16)20(27-28)29-19-12(11-21)4-2-9-23-19;2*1-12-5-3-7-17(22-12)28-20-14-9-8-13(11-16(14)27(2)26-20)23-19-18-15(24-25-19)6-4-10-21-18;1-27-17-11-14(23-19-18-16(24-25-19)3-2-8-22-18)4-5-15(17)20(26-27)28-12-13-6-9-21-10-7-13;1-26-15-11-12(22-18-17-14(23-24-18)5-4-10-21-17)7-8-13(15)19(25-26)27-16-6-2-3-9-20-16/h1,4-12H,2H3,(H2,24,25,26);2-10H,1H3,(H2,24,25,26);2*3-11H,1-2H3,(H2,23,24,25);2-11H,12H2,1H3,(H2,23,24,25);2-11H,1H3,(H2,22,23,24)
InChIKeyNXLQMERIPUBMDO-UHFFFAOYSA-N
MW2235.37 g/mol
LogP22.91
Rot. Bonds25

About N-[3-[(5-ethynyl-2-pyridinyl)oxy]-1-methylindazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;bis(N-[1-methyl-3-[(6-methyl-2-pyridinyl)oxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine);2-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]oxypyridine-3-carbonitrile;N-[1-methyl-3-(pyridin-4-ylmethoxy)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-pyridin-2-yloxyindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine

N-[3-[(5-ethynyl-2-pyridinyl)oxy]-1-methylindazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;bis(N-[1-methyl-3-[(6-methyl-2-pyridinyl)oxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine);2-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]oxypyridine-3-carbonitrile;N-[1-methyl-3-(pyridin-4-ylmethoxy)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-pyridin-2-yloxyindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine (PubChem CID 159913345) has the molecular formula C120H95N43O6 and a molecular weight of 2235.37 g/mol. Its IUPAC name is N-[3-[(5-ethynyl-2-pyridinyl)oxy]-1-methylindazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;bis(N-[1-methyl-3-[(6-methyl-2-pyridinyl)oxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine);2-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]oxypyridine-3-carbonitrile;N-[1-methyl-3-(pyridin-4-ylmethoxy)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-pyridin-2-yloxyindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine.

Molecular Properties

Compound NameN-[3-[(5-ethynyl-2-pyridinyl)oxy]-1-methylindazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;bis(N-[1-methyl-3-[(6-methyl-2-pyridinyl)oxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine);2-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]oxypyridine-3-carbonitrile;N-[1-methyl-3-(pyridin-4-ylmethoxy)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-pyridin-2-yloxyindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine
PubChem CID159913345
Molecular FormulaC120H95N43O6
Molecular Weight2235.37 g/mol
Exact Mass2233.85
IUPAC NameN-[3-[(5-ethynyl-2-pyridinyl)oxy]-1-methylindazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;bis(N-[1-methyl-3-[(6-methyl-2-pyridinyl)oxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine);2-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]oxypyridine-3-carbonitrile;N-[1-methyl-3-(pyridin-4-ylmethoxy)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-pyridin-2-yloxyindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine
SMILESC#Cc1ccc(Oc2nn(C)c3cc(Nc4n[nH]c5cccnc45)ccc23)nc1.Cc1cccc(Oc2nn(C)c3cc(Nc4n[nH]c5cccnc45)ccc23)n1.Cc1cccc(Oc2nn(C)c3cc(Nc4n[nH]c5cccnc45)ccc23)n1.Cn1nc(OCc2ccncc2)c2ccc(Nc3n[nH]c4cccnc34)cc21.Cn1nc(Oc2ccccn2)c2ccc(Nc3n[nH]c4cccnc34)cc21.Cn1nc(Oc2ncccc2C#N)c2ccc(Nc3n[nH]c4cccnc34)cc21
InChIInChI=1S/C21H15N7O.C20H14N8O.3C20H17N7O.C19H15N7O/c1-3-13-6-9-18(23-12-13)29-21-15-8-7-14(11-17(15)28(2)27-21)24-20-19-16(25-26-20)5-4-10-22-19;1-28-16-10-13(24-18-17-15(25-26-18)5-3-8-22-17)6-7-14(16)20(27-28)29-19-12(11-21)4-2-9-23-19;2*1-12-5-3-7-17(22-12)28-20-14-9-8-13(11-16(14)27(2)26-20)23-19-18-15(24-25-19)6-4-10-21-18;1-27-17-11-14(23-19-18-16(24-25-19)3-2-8-22-18)4-5-15(17)20(26-27)28-12-13-6-9-21-10-7-13;1-26-15-11-12(22-18-17-14(23-24-18)5-4-10-21-17)7-8-13(15)19(25-26)27-16-6-2-3-9-20-16/h1,4-12H,2H3,(H2,24,25,26);2-10H,1H3,(H2,24,25,26);2*3-11H,1-2H3,(H2,23,24,25);2-11H,12H2,1H3,(H2,23,24,25);2-11H,1H3,(H2,22,23,24)
InChIKeyNXLQMERIPUBMDO-UHFFFAOYSA-N
XLogP22.91
TPSA585.03 Ų
H-Bond Donors12
H-Bond Acceptors43
Rotatable Bonds25
Heavy Atoms169
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002235.37
LogP ≤ 522.91
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1043

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze N-[3-[(5-ethynyl-2-pyridinyl)oxy]-1-methylindazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;bis(N-[1-methyl-3-[(6-methyl-2-pyridinyl)oxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine);2-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]oxypyridine-3-carbonitrile;N-[1-methyl-3-(pyridin-4-ylmethoxy)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-pyridin-2-yloxyindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[3-[(5-ethynyl-2-pyridinyl)oxy]-1-methylindazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;bis(N-[1-methyl-3-[(6-methyl-2-pyridinyl)oxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine);2-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]oxypyridine-3-carbonitrile;N-[1-methyl-3-(pyridin-4-ylmethoxy)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-pyridin-2-yloxyindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine?
The IUPAC name of N-[3-[(5-ethynyl-2-pyridinyl)oxy]-1-methylindazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;bis(N-[1-methyl-3-[(6-methyl-2-pyridinyl)oxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine);2-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]oxypyridine-3-carbonitrile;N-[1-methyl-3-(pyridin-4-ylmethoxy)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-pyridin-2-yloxyindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine (CID 159913345) is N-[3-[(5-ethynyl-2-pyridinyl)oxy]-1-methylindazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;bis(N-[1-methyl-3-[(6-methyl-2-pyridinyl)oxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine);2-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]oxypyridine-3-carbonitrile;N-[1-methyl-3-(pyridin-4-ylmethoxy)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-pyridin-2-yloxyindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine.
What is the SMILES notation for N-[3-[(5-ethynyl-2-pyridinyl)oxy]-1-methylindazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;bis(N-[1-methyl-3-[(6-methyl-2-pyridinyl)oxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine);2-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]oxypyridine-3-carbonitrile;N-[1-methyl-3-(pyridin-4-ylmethoxy)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-pyridin-2-yloxyindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine?
The canonical SMILES for N-[3-[(5-ethynyl-2-pyridinyl)oxy]-1-methylindazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;bis(N-[1-methyl-3-[(6-methyl-2-pyridinyl)oxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine);2-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]oxypyridine-3-carbonitrile;N-[1-methyl-3-(pyridin-4-ylmethoxy)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-pyridin-2-yloxyindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine is C#Cc1ccc(Oc2nn(C)c3cc(Nc4n[nH]c5cccnc45)ccc23)nc1.Cc1cccc(Oc2nn(C)c3cc(Nc4n[nH]c5cccnc45)ccc23)n1.Cc1cccc(Oc2nn(C)c3cc(Nc4n[nH]c5cccnc45)ccc23)n1.Cn1nc(OCc2ccncc2)c2ccc(Nc3n[nH]c4cccnc34)cc21.Cn1nc(Oc2ccccn2)c2ccc(Nc3n[nH]c4cccnc34)cc21.Cn1nc(Oc2ncccc2C#N)c2ccc(Nc3n[nH]c4cccnc34)cc21.
What is the InChIKey of N-[3-[(5-ethynyl-2-pyridinyl)oxy]-1-methylindazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;bis(N-[1-methyl-3-[(6-methyl-2-pyridinyl)oxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine);2-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]oxypyridine-3-carbonitrile;N-[1-methyl-3-(pyridin-4-ylmethoxy)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-pyridin-2-yloxyindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine?
The InChIKey is NXLQMERIPUBMDO-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H15N7O.C20H14N8O.3C20H17N7O.C19H15N7O/c1-3-13-6-9-18(23-12-13)29-21-15-8-7-14(11-17(15)28(2)27-21)24-20-19-16(25-26-20)5-4-10-22-19;1-28-16-10-13(24-18-17-15(25-26-18)5-3-8-22-17)6-7-14(16)20(27-28)29-19-12(11-21)4-2-9-23-19;2*1-12-5-3-7-17(22-12)28-20-14-9-8-13(11-16(14)27(2)26-20)23-19-18-15(24-25-19)6-4-10-21-18;1-27-17-11-14(23-19-18-16(24-25-19)3-2-8-22-18)4-5-15(17)20(26-27)28-12-13-6-9-21-10-7-13;1-26-15-11-12(22-18-17-14(23-24-18)5-4-10-21-17)7-8-13(15)19(25-26)27-16-6-2-3-9-20-16/h1,4-12H,2H3,(H2,24,25,26);2-10H,1H3,(H2,24,25,26);2*3-11H,1-2H3,(H2,23,24,25);2-11H,12H2,1H3,(H2,23,24,25);2-11H,1H3,(H2,22,23,24).
What are the key properties of N-[3-[(5-ethynyl-2-pyridinyl)oxy]-1-methylindazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;bis(N-[1-methyl-3-[(6-methyl-2-pyridinyl)oxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine);2-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]oxypyridine-3-carbonitrile;N-[1-methyl-3-(pyridin-4-ylmethoxy)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-pyridin-2-yloxyindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine?
N-[3-[(5-ethynyl-2-pyridinyl)oxy]-1-methylindazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;bis(N-[1-methyl-3-[(6-methyl-2-pyridinyl)oxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine);2-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]oxypyridine-3-carbonitrile;N-[1-methyl-3-(pyridin-4-ylmethoxy)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-pyridin-2-yloxyindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine has a molecular weight of 2235.37 g/mol, XLogP of 22.91, 25 rotatable bonds, 12 hydrogen bond donors, and 43 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-[(5-ethynyl-2-pyridinyl)oxy]-1-methylindazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;bis(N-[1-methyl-3-[(6-methyl-2-pyridinyl)oxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine);2-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]oxypyridine-3-carbonitrile;N-[1-methyl-3-(pyridin-4-ylmethoxy)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-pyridin-2-yloxyindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine is sourced from PubChem (CID 159913345), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).